acquired
Stage
2020
Founded
2
Investors
About
Tetra Therapeutics was a discovery-based biopharmaceutical company focused on developing treatments for neurodevelopmental disorders such as Fragile X syndrome, and its clinical programs were acquired and are now managed by Shionogi Inc.
Explore Tetra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.